Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Scott A Armstrong
Affiliation
Boston Children's Hospital
ORCID
Career Start Year
1990
Papers
207
H Index
74
Expertise
CM4AI Collaborator
Timothy Clark (CM4AI)
PMID
Paper Title
Journal Title
Published Year
38096371
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML.
Blood
2024
38010951
The future of HOXA- expressing leukemias: Menin inhibitor response and resistance.
Curr Opin Hematol
2024
38096371
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML.
Blood
2024
38010951
The future of HOXA- expressing leukemias: Menin inhibitor response and resistance.
Curr Opin Hematol
2024
36264143
A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition.
Cancer Discov
2023
36264143
A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition.
Cancer Discov
2023
37591951
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer.
Nat Cell Biol
2023
37648862
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia.
Nature
2023
38049829
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.
Mol Cancer
2023
37478846
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability.
Mol Cell
2023
37261974
MLL3 regulates the <i>CDKN2A</i> tumor suppressor locus in liver cancer.
Elife
2023
36922593
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.
Nature
2023
36922589
MEN1 mutations mediate clinical resistance to menin inhibition.
Nature
2023
36455613
Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia.
Cancer Discov
2023
37591951
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer.
Nat Cell Biol
2023
37478846
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability.
Mol Cell
2023
37648862
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia.
Nature
2023
38049829
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.
Mol Cancer
2023
37261974
MLL3 regulates the <i>CDKN2A</i> tumor suppressor locus in liver cancer.
Elife
2023
36922593
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.
Nature
2023
36922589
MEN1 mutations mediate clinical resistance to menin inhibition.
Nature
2023
36455613
Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia.
Cancer Discov
2023
34582559
The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML.
Blood
2022
35523139
Antigen presentation safeguards the integrity of the hematopoietic stem cell pool.
Cell Stem Cell
2022
35443279
SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis.
Cancer Discov
2022
35499757
MOZ and Menin-MLL Complexes Are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor.
Cancer Discov
2022
35534777
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia.
Nat Cancer
2022
34465866
YBX1 mediates translation of oncogenic transcripts to control cell competition in AML.
Leukemia
2022
35245435
MLL::AF9 degradation induces rapid changes in transcriptional elongation and subsequent loss of an active chromatin landscape.
Mol Cell
2022
35078859
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia.
Clin Cancer Res
2022
35072375
Menin Inhibitors in Acute Myeloid Leukemia-What Does the Future Hold?
Cancer J
2022
34582559
The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML.
Blood
2022
35443279
SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis.
Cancer Discov
2022
35534777
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia.
Nat Cancer
2022
35499757
MOZ and Menin-MLL Complexes Are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor.
Cancer Discov
2022
35523139
Antigen presentation safeguards the integrity of the hematopoietic stem cell pool.
Cell Stem Cell
2022
35072375
Menin Inhibitors in Acute Myeloid Leukemia-What Does the Future Hold?
Cancer J
2022
35245435
MLL::AF9 degradation induces rapid changes in transcriptional elongation and subsequent loss of an active chromatin landscape.
Mol Cell
2022
35078859
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia.
Clin Cancer Res
2022
34465866
YBX1 mediates translation of oncogenic transcripts to control cell competition in AML.
Leukemia
2022
32730721
IL-1α Modulates IFN-γ-Induced Production of CXCL9/MIG during Herpes Simplex Virus Type-1 Corneal Infection.
Curr Eye Res
2021
34156981
Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates by cleaving TFIIA.
JCI Insight
2021
34210975
High-resolution characterization of gene function using single-cell CRISPR tiling screen.
Nat Commun
2021
33451979
HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor.
Clin Cancer Res
2021
33879367
Histone PTM Crosstalk Stimulates Dot1 Methyltransferase Activity.
Trends Biochem Sci
2021
32730721
IL-1α Modulates IFN-γ-Induced Production of CXCL9/MIG during Herpes Simplex Virus Type-1 Corneal Infection.
Curr Eye Res
2021
33879367
Histone PTM Crosstalk Stimulates Dot1 Methyltransferase Activity.
Trends Biochem Sci
2021
34156981
Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates by cleaving TFIIA.
JCI Insight
2021
34210975
High-resolution characterization of gene function using single-cell CRISPR tiling screen.
Nat Commun
2021
33451979
HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor.
Clin Cancer Res
2021
1 - 50 of 414
Column Actions
Search
Recommended Authors
Zachary Schonrock
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2016
Number of shared co-authors
1
Alex Murison
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2012
Number of shared co-authors
5
Tamara L Lamprecht
St. Jude Children's Research Hospital
Career Start Year
2010
Number of shared co-authors
5
Biniam Adane
The Broad Institute of MIT and Harvard
Career Start Year
2010
Number of shared co-authors
8
Julia E Maxson
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2009
Number of shared co-authors
9
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2006
Number of shared co-authors
7
Bastien Gerby
Universite de Toulouse, Inserm, Universite Toulouse III-Paul Sabatier
Career Start Year
2005
Number of shared co-authors
5
Zejuan Li
Houston Methodist Hospital
Career Start Year
2005
Number of shared co-authors
3
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year
2004
Number of shared co-authors
3
Giovanni Roti
University of Parma
Career Start Year
2003
Number of shared co-authors
18
Rhonda E Ries
Clinical Research Division, Fred Hutchinson Cancer Research Center
Career Start Year
2003
Number of shared co-authors
14
Christopher C Porter
Emory University School of Medicine
Career Start Year
2003
Number of shared co-authors
5
Anna L Brown
Adelaide Medical School, University of Adelaide
Career Start Year
2003
Number of shared co-authors
11
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Career Start Year
2002
Number of shared co-authors
28
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year
2001
Number of shared co-authors
3
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
9
Ravindra Majeti
Stanford University School of Medicine
Career Start Year
1998
Number of shared co-authors
9
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year
1998
Number of shared co-authors
3
Kolja Eppert
McGill University
Career Start Year
1996
Number of shared co-authors
7
Yongjin Li
Mayo Clinic
Career Start Year
1995
Number of shared co-authors
10
Lucy A Godley
The University of Chicago
Career Start Year
1994
Number of shared co-authors
15
Mar??a D Odero
University of Navarra
Career Start Year
1994
Number of shared co-authors
2
Timothy A Graubert
Massachusetts General Hospital
Career Start Year
1993
Number of shared co-authors
12
Seishi Ogawa
Kyoto University
Career Start Year
1993
Number of shared co-authors
15
Jean Soulier
University of Paris
Career Start Year
1993
Number of shared co-authors
13
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year
1992
Number of shared co-authors
8
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year
1992
Number of shared co-authors
5
Geoffrey Neale
St. Jude Children's Research Hospital
Career Start Year
1989
Number of shared co-authors
8
Feyruz V Rassool
University of Maryland Greenebaum Comprehensive Cancer Center
Career Start Year
1984
Number of shared co-authors
2
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Career Start Year
1980
Number of shared co-authors
22
row(s) 1 - 30 of 30
Collaborators
Richard Koche
Memorial Sloan Kettering Cancer Center
Co-authored papers
26
Amit U Sinha
Memorial Sloan Kettering Cancer Center
Co-authored papers
21
Aniruddha J Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
14
Nan Zhu
Shanghai General Hospital, Shanghai Jiaotong University
Co-authored papers
12
Charlie Hatton
Co-authored papers
12
James E Bradner
Co-authored papers
12
Elisa de Stanchina
Co-authored papers
9
Ari Melnick
Co-authored papers
9
Gerard M McGeehan
Co-authored papers
8
Benjamin L Ebert
Co-authored papers
8
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Co-authored papers
7
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers
7
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Co-authored papers
7
Mithat Gonen
Co-authored papers
6
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Co-authored papers
5
Brenton G Mar
Co-authored papers
5
Stuart H Orkin
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers
5
Kimberly Stegmaier
Dana-Farber Cancer Institute
Co-authored papers
5
James J Hsieh
Washington University
Co-authored papers
5
Jun Qi
Dana-Farber Cancer Institute
Co-authored papers
4
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Co-authored papers
4
David E Root
Broad Institute of Harvard and MIT
Co-authored papers
4
David T Scadden
Co-authored papers
4
Christopher E Mason
Feil Family Brain and Mind Research Institute.
Co-authored papers
4
Robert G Roeder
the Rockefeller University
Co-authored papers
4
Richard M Stone
Dana Farber Cancer Institute
Co-authored papers
4
Eric Still
Co-authored papers
4
Brian J P Huntly
University of Cambridge
Co-authored papers
4
Yana Pikman
Dana Farber Cancer Institute
Co-authored papers
4
Victoria M Richon
Discovery and Preclinical Sciences
Co-authored papers
4
1 - 30